Background & Aim: Nesfatin-1 is a novel anorectic neuropeptide with potent metabolic regulatory effects. Our aim is to investigate the association of nesfatin-1 levels and cardiac syndrome X (CSX).
Introduction
Pain or pressure on chest is responsible for over 5 million individuals taken to emergency services in hospitals, annually [1] . Among these patients, cardiac syndrome X (CSX) cases are substantial in number. If chest pain is caused by angina or ischemia using cardiovascular strest test or myocardial perfusion scintigraphy (MPS) without (AMI) compared to the angina pectoris group and the control group, in a study involving 156 individuals. In addition, plasma nesfatin-1 levels were inversely correlated with high sensitivity C reactive protein (hs-CRP), neutrophil percentage, and Gensini score in the AMI group. They reported that low levels of nesfatin-1 may have an important role in the development of AMI [7] . It has been shown that nesfatin-1 has an effect on inflammation and coronary artery disease [7] . The aim of the present study is to assess the association of nesfatin-1 with cardiac syndrome X.
Materials and Methods

Patient Characteristics
The study group consist of 80 patients who underwent coronary angiography on an outpatient basis at the cardiology department of Sivas Numune Hospital between October 2015-April 2017 and were diagnosed as CSX according to the presence of exercise-induced typical angina pectoris and ischemia on myocardial perfusion scintigraphy with angiographically normal coronary arteries. For the control group, consecutive 80 individuals with no diagnosis on stress test were designated as gender-and age-matched. Exclusions were the cases with unstable pain on chest, previous MI, coronary vasosplasm and coronary atherosclerosis (inc. plaque and ectasia), valvular heart disease (except for mild), impaired kidney (SCr > 1.5 mg/dl in males and >1.4 mg/dl in females), and liver function (more than doubled the peak as lab ref.), systolic impairment in left ventriclesby echocardiography (EF <0.40) malignant tumors, haematological diseases, chronic or acute infection or inflammation, or steroid treatment.
For the diagnosis of hypertension should be systolic blood pressure of > 140 mm Hg or diastolic blood pressure of > 90 mm Hg or the current use of antihypertensive drugs. Diabetes mellitus was defined as the use of antidiabetic medication or a fasting blood glucose of ≥ 126 mg/dl. Smoking was described as the regular use of tobacco.
Coronary Angiography
During coronary angiography, Judkins method was applied as standard, in which femoral or radial catheter was used for coronary angiograms, and two angiography practitioners uninformed of the lab and test results examined them.
As channel blockers, no adenosine, nitroglycerin or calcium were administered. Hyperventilation test was performed to detect arterial spasm and exclude the diagnosed patients. Coronary arteries were accepted as abnormal when any illuminated narrowing or irregularity was recognized.
Laboratory Measurements
Samples were taken from the peripheral veins of the patients having undergone fast during the previous night.Autoanalyzers were used to evaluate the hematological results; Abbott Cell-Dyn 3700 for the leukocyte counts,totally or differently, and Abbott Architect C16000 auto-analyzer for high-density lipoprotein (HDL) cholesterol, triglycerides, and fasting blood glucose levels on blood serum, totally and specifically(Abbott Lab, Abbott Park, IL, USA). The Friedewald equation was the formula to make computations of the concentrations of serum low-density lipoprotein (LDL) cholesterol.
The technique of immediate centrifugation and cold storage (-80°C) was applied for plasmas taken to measure nesfatin-1 levels for a length of time. On the analysis day, the measurements were realized through a commercial ELISA kit (Ranging: 31.2 to 2000 pg/mL, Sensitivity: < 10 pg/mL) (Enzyme-Linked ImmunoSorbent Assay, Boster
Immunoleader, USA) in compliance with the guiding protocol, its appendix. Table 1 : Baseline characteristics of the study groups (n = 160)
Statistical analysis
Data are given as mean ± standard deviation or number (percentage); CSX: Cardiac syndrome X Table 2 shows laboratory results of the cases and other subjects. There is significant difference between Hs-CRP levels of the individuals in study and control groups (p=0.028). Nesfatin-1 levels measured on plasma samples from the patients were significantly lower than those from the control subjects (p < 0.001). Multivariate logistic regression analysis was conducted in order to revealpotential perplexing pathogenic causes of CSX disease, and nesfatin-1 levels were low in significant and independent association with CSX (OR: 0.982; 0.969-0.995 at 95% CI, p=0.005) (see Table 3 ). Table 3 : Multivariate logistic regression analysis predicting cardiac syndrome X CI -confidence interval; Hs-CRP -high-sensitivity C-reactive protein; OR -odds ratio
Parameters Control group (n = 80) Patients with CSX (n = 80) p
Discussion
It was revealed that nesfatin-1 levels were significantly lower in patients with CSX than patients in control group, in the present study.
Out of the patients who have typical complains and test results of angina pectoris, 10% to 30% are categorized as "normal" or "near normal" in terms of their epicardial arteries recognized under on coronary angiography. Among those cases, the individuals with pain or pressure on chest, which is mostly provoked by exercises, have narrowing or irregularities on myocards and/or ST segment depression, ischemia-like discomfort on chest, induced by any factor or not, and they are evaluated as CSX in studies. Nevertheless, a group of patients due to hypertrophy in left ventricles, spasm in coronary arteries, and cardiomyopathy must have been excluded when arrived at the evaluation stage.
All these exlusions mean much more labor and money for our health care sector to discover the real factors of chest pain, spent on diagnosis tests and laboratory works which are substantially expensive. Moreover, CSX diagnosis vitally reduces the quality of life even though there is no additional risk of death.
This diagnostic case includes heterogeneity among any could-be pathogenetic factors, even derived from noncardiac effects. The most notorious one is impaired endothelium in the collateral coronary circulation [8, 9] .
there. Its increasing quantity when dilated, as "coronary blood flow reserve", primarily indicates the vasodilator capacity in microcirculation. If the artery has more resistance and/or less reserve, the spread between the demand and supply may not be closed, leading to myocardial ischemia, contributing factor to the pathogenesis of CSX disease, called 'microvascular angina'. The real cause or maybe causes for such coronary irregularities have not yet been totally discovered.
Despite that defect, the appearance of CSX is often attributed to they way of its reflection like chest pain and behind this, myocardial ischemia and endothelial impairment as well [3] . In patophysiology, CSX appears with the mechanisms in which metabolism is insulin-resistant, auto-control irregular, and microcirculation spasmodic. The most reasonable evidence is impairment on endothelium that causes to diminish the quantity of nitric oxide and hence the quality of any agents against inflammation and coagulation and derange the balance of constriction and dilation in vascular arteries [10] . Among these patients, the amount of nitric oxide is reduced up to basal levels while endothelin-1 levels are increasing [11] .
The impaired endothelium could be mainly the best precursor for higherlikelihood of adverse consequences [12] . In literature the studies on the relationship of CSX and inflammatory response come up with innovative approachs for treatment of such a puzzling condition. For instance, for CSX patients early detection of symptoms like severe and repetitive angina pectoris could be possible by means of monitoring construction of arteries' wall and their function through inflammatory markers as well as noninvasive measures.This facility can also be beacon of hope for those patients having poor endothelium with no better chance of prognosis, even with aggressive operations.Furthermore, intravascular ultrasonograpy has developed so that CSX patients can be provided more specific diagnosis like with plaques in atheroma and thicknesses in intima [13] .
There is in addition association between impairment in endothelium and more CRP markers for chronic vasoinflammatory conditions [14] . The relationship of CSX patients' virtually incessant pain on chest and higher CRP levels have been proven as well as with greater number of ischemic episodes identified through 24-hour Holter monitoring [15] . CRP, a biomarker of inflammation, is naturally rising with inflammatory responses in the cases of pain, injury, infection, etc. [16] , and so the angina presence increased as a result of ischemic events, per se, must be increasing factor for CRP. Nonetheless, regardless of chest pain, in fact, CRP is not only a direct response to pain but also CRP levels have pathogenic impact on CSX separately, on the ground that CRP is related to the ischemiaoriented episodes. As related to CSX, the connection of CRP levels and carotid artery stiffness has in the meantime been discovered [17] ; among CSX patients CRP levels were significantly higher than normal as well as a stiff carotid artery. Additionally, there may exist a causality between inflammation and impairment of endothelium along with their would-be common factor, the present plaque in subclinical atherosclerosis.
Some studies in the last decade have demonstrated that pathological functions of adipose tissue can be associated with increased cardiovascular disease risk, not only due to the effect of the hypothalamus nucleus [4] on the regulation of cardiovascular function but also by activating the autocrine/paracrine/endocrine pathway of chemical mediators released from adipose tissue like nesfatin-1 [18] . A major hormone giving sense of satiety is Nesfatin-1 [4] . In a number of trials conducted over the rats, Nesfatin-1 was intracerebroventricularly administered or intraperitoneally applied, and then dietary intake was reduced [4] . This type of peptide is related to hepatic (esp. diabetes mellitus) [19] , polycystic (in particular, ovarian syndrome (PCOS) [20] , psychiatric (21) or neurogenic [22] dysfunctions, as reported in recent times.
Bonnet et al. [23] have revealed an association between inflammation of the brainstem and hypothalamus and activation of neuron expressing nesfatin- [7] have reported that plasmic concentrations of nesfatin-1 were substantially decreased among patients with AMI. Moreover, these concentrations have negative association with CRP and neutrophil percentage, which are important predictors of CSX development, in AMI patients [7] .
Osaki et al. [27] showed that 6-hydroxydopamine, which makes chemical sympathectomy, might rise the presence of nesfatin/nucleobind-2 in thickened subcutaneous tissues. Thus, it could possibly be inferred that the expression of nesfatin-1 could be suppressed by sympathetic activity could suppress nesfatin-1 expression. Increased activity relating to sympathetic nervous system is also closely associated with endothelial dysfunction [28] .
In this study, we have consensus with the finding of Rencio Mayoral et. al.
[29] and Rinkevich et. al.
[30] that myocardial microcirculation system could be impaired by subclinical inflammatory responses though epicardial blood flow is normal in coronary arteries.
We conclude that among CSX patients plasmatic concentration of nesfatin-1 is lower than normal, which could have pathogenic impact on CSX phenomenon with a number of factors including inflammatory responses and impaired endothelium. We consider that the relationship between CSX and nesfatin-1 should be challenged with further researches.
